Literature DB >> 198332

Effect of cholecystokinin variant (CCK39) on dispersed acinar cells from guinea pig pancreas.

L Sjodin, J D Gardner.   

Abstract

In dispersed acinar cells from guinea pig pancreas, cholecystokinin variants (CCK39 and CCK33) or carboxyl-terminal octapeptide of cholecystokinin (CCK-OP) caused significant increases in outflux of 45Ca, cyclic GMP, and release of amylase. In homogenates of acinar cells each peptide caused a significant increase in adenylate cyclase activity. For each function tested (1) CCK39 was equipotent with with CCK33, (2) CCK39 and CCK33 were 10 to 30 times less potent than CCK-OP, (3) the efficacies of CCK39, CCK33, and CCK-OP were the same, and (4) none of these effects were altered by concentrations of atropine sufficient to abolish the action of muscarinic cholinergic agents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198332

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Biochemical basis of action of gastrointestinal hormones.

Authors:  J D Gardner
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

2.  Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells.

Authors:  R T Jensen; G F Lemp; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

Review 3.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

4.  Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion.

Authors:  B Ahrén; I Lundquist
Journal:  Acta Diabetol Lat       Date:  1981 Oct-Dec

Review 5.  Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes.

Authors:  Qiang Zeng; Lei Ou; Wei Wang; Dong-Yu Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.